Contributor Page
Mintz
 
Email  |  Website  |  Articles
Contact Details
Tel: +1 617 5426000
Fax: +1 617 5422241
One Financial Center
Boston
MA 02111
United States
By Aarti Shah, Rithika Kulathila
In Amarin Pharma, Inc. v. Int'l Trade Comm'n (18-1247), the Federal Circuit affirmed the International Trade Commission's ("ITC") finding that Amarin's false advertising claim under § 43(a) of the Lanham Act was precluded by the Federal Food, Drug, and Cosmetic Act
By Samuel Tony Starr, Kevin Mortimer
In a recent decision, the Supreme Judicial Court of Massachusetts (SJC) has held that a contractor seeking to enforce a lien dissolution bond under G.L. c. 254 § 14 need not record an attested to copy of its complaint with the Registry of Deeds.
By Thomas Crane, Laurence Freedman, Daryl M. Berke
On June 3, 2019, the U.S. Supreme Court issued a decision in Azar v. Allina Health Services. The case involved a challenge by hospitals over whether the Department of Health and Human Services
By Andrew DeVoogd, Courtney Herndon
Recently, in a patent infringement action pending in the Eastern District of Michigan, Webasto Thermo & Comfort N. Am., Inc. v. BesTop, Inc., No. 2:16-cv-13456.
By Susan Cohen
On June 1, 2019 the Department of State (DOS) announced that it would immediately begin requiring visa applicants to the United States to provide additional personal information on U.S. visa applications
By Kristen A. Marotta
Medical Informatics Engineering, Inc. and its wholly-owned subsidiary, NoMoreClipboard, LLC, an electronic medical record and software services provider is now liable for a combined total of $1 million...
By Karen Lovitch, Matt Mora
Earlier this week the OIG took the somewhat unusual step of issuing a fraud alert directed to Medicare beneficiaries (rather than to Medicare providers) regarding "fraud schemes"
By Michael Renaud, James Wodarski, Aarti Shah, Matthew Galica
A recent decision in the Eastern District of Texas should provide standard-essential patent ("SEP") owners with more clarity and optimism when negotiating SEP licenses.
By Donald C. Davis
Virginia has long been one of the states not requiring employers to provide employees access to their personnel records.
By Michelle L. Caton
In the ongoing public dialogue about prescription drug affordability, Maryland seems poised to lead the way for states considering a new way to rein in drug spending: drug affordability boards. This spring, the Maryland General Assembly passed
By Bridgette Keller, Daryl M. Berke, Lauren M. Moldawer
Earlier this month, CMS issued a final rule aimed at lowering drug prices and reducing out-of-pocket expenses in Medicare Advantage and Medicare Part D.
By Timothy McKeon
On May 20, 2019, the United States Supreme Court ruled that a debtor-licensor's ‘rejection' of a trademark license agreement under section 365 of the Bankruptcy Code does not terminate the licensee's rights...
By Michael Renaud, Bruce Sokler, Richard Gervase, Harold S. Laidlaw
Just when observers thought Qualcomm could celebrate its successful litigation with Apple another decision has come down which could have major implications for Qualcomm's business going forward.
By Daniel Weinger, Kristina Cary, Serge Subach, William Perkins
Services play a large role in today's economy, and it is important to be mindful of how certain pitfalls that apply to product-based intellectual property rights also apply to method
By Benjamin Zegarelli
On May 14, FDA announced that it issued five Warning Letters to companies that manufacture and market homeopathic drugs for human use. Four of the letters were issued to four companies that jointly manufacture and package
Contributor's Topics
More...